Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis

Circulation

Volumn 107, Issue 9, 2003, Pages 1303-1307

  Solomon, Daniel H ^a   Karlson, Elizabeth W ^a   Rimm, Eric B ^b   Cannuscio, Carolyn C ^c   Mandl, Lisa A ^a   Manson, JoAnn E ^a   Stampfer, Meir J ^a,b   Curhan, Gary C ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cardiovascular diseases; Epidemiology; Myocardial infarction; Stroke

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CORONARY RISK; DISEASE ASSOCIATION; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORBIDITY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SELF REPORT; STROKE;

ADULT; ARTHRITIS, RHEUMATOID; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0037432305     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000054612.26458.B2     Document Type: Article

References (31)

1. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41:778-799.
2. Cobb S, Anderson F, Bauer W. Length of life and cause of death in rheumatoid arthritis. N Engl J Med. 1953;249:553-556.
3. Allebeck P. Increased mortality in rheumatoid arthritis. Scand J Rheumatol. 1982;11:81-86.
4. Pincus T, Callahan LF, Sale WG, et al. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum. 1984;27:864-872.
5. Wolfe F, Mitchell DM, Sibley JT, et al. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994;37:481-494.
6. Monson RR, Hall AP. Mortality among arthritics. J Chron Dis. 1976;29: 459-467.
7. Myllykangas-Luosujaarvi R, Aho K, Kautiainen H, et al. Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol. 1995;22: 1065-1067.
8. Wallberg Jonsson S, Ohman ML, Dahlqvist SR. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol. 1997;24:445-451.
9. Rincon ID, Williams K, Stern MP, et al. High incidence of cardiovascular events in a rheumatoid arthritis not explained by traditional cardiovascular risk factors. Arthritis Rheum. 2001;44:2737-2748.
10. Ross R. Atherosclerosis: an inflammaatory disease. N Engl J Med. 1999; 340:115-126.
11. Lee D, Weinblatt M. Rheumatoid arthritis. Lancet. 2001;358:903-911.
12. Weyand CM, Gornzy JJ, Luizzo G, et al. T-cell immunity in acute coronary syndromes. Mayo Clin Proc. 2001;76:1011-1020.
13. Liuzzo G, Goronzy JJ, Yang H, et al. Monoclonal T-cell proliferation and instability in acute coronary syndromes. Circulation. 2001;101: 2883-2888.
14. Liuzzo G, Biasucci LM, Gallimore R, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331:417-424.
15. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-999.
16. Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731-733.
17. Choi HK, Heman MA, Seeger JD, et al. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002;359: 1173-1177.
18. Colditz GA, Manson JE, Hankinson SE. The Nurses' Health Study. 20-year contribution to the understanding of health among women. J Womens Health. 1997;6:49-62.
19. Karlson EW, Sanchez-Guerrero J, Wright EA, et al. A connective tissue disease screening questionnaire for population studies. Ann Epidemiol. 1995;5:297-302.
20. Arnett FC, Edworthy S, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheumat. 1988;31:315-324.
21. Rose GA, Blackburn H. Cardiovascular Survey Methods. 2nd ed. Geneva: World Health Organization; 1982. World Health Organization monograph series No. 56.
22. Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke: clinical findings. Stroke. 1981;12:113-144.
23. Stampfer MJ, Willett WC, Speizer FE, et al. Test of the National Death Index. Am J Epidemiol. 1984;119:837-839.
24. D'Agostino RB Lee M-L, Belanger AJ, et al. Relation of pooled logistic regression to time-dependent regression analysis: the Framingham Heart Study. Stat Med. 1990;9:1501-1515.
25. Nashel DJ. Is atherosclerosis a complication of long-term corticosteroid treatment? Am J Med. 1986;80:925-929.
26. Morgan SL, Baggott JE, Lee JY, et al. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during long-term, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. J Rheumatol. 1998;25:441-446.
27. Wallace DJ, Metzger AL, Turnbull BA. Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids. Am J Med. 1990;89:322-326.
28. Petri M. Hydroxychloroquine use in the Baltimore lupus cohort: effects on lipids, glucose and thrombosis. Lupus. 1996;5:S16-S22.
29. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med. 2000;343:1520-1528.
30. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338: 1516-1520.
31. MacLean CH, Louie R, Leake B, et al. Quality of care for patients with rheumatoid arthritis. JAMA. 2000;284:984-992.